Global Erythropoietin Stimulating Agents Market Report 2019, Competitive Landscape, Trends and Opportunities
The Erythropoietin Stimulating Agents market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Erythropoietin Stimulating Agents market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Erythropoietin Stimulating Agents market.
Major players in the global Erythropoietin Stimulating Agents market include:
Celon Labs
Celltrion, Inc.
LG Life Sciences Ltd.
Hospira Inc.
Probiomed
Intas Pharmaceuticals
Ranbaxy Laboratories Ltd.
Roche
Zuventus Health Care
Serum Institute of India
VHB Life Sciences Ltd.
Teva Pharmaceutical Industries Ltd.
Wockhardt Limited
Amgen Inc.
Johnson & Johnson
Biosidus
Biocon
Blausiegel
On the basis of types, the Erythropoietin Stimulating Agents market is primarily split into:
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
On the basis of applications, the market covers:
Cancer
Hematology
Renal Diseases
Neurology
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Erythropoietin Stimulating Agents market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Erythropoietin Stimulating Agents market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Erythropoietin Stimulating Agents industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Erythropoietin Stimulating Agents market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Erythropoietin Stimulating Agents, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Erythropoietin Stimulating Agents in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Erythropoietin Stimulating Agents in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Erythropoietin Stimulating Agents. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Erythropoietin Stimulating Agents market, including the global production and revenue forecast, regional forecast. It also foresees the Erythropoietin Stimulating Agents market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Erythropoietin Stimulating Agents market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Erythropoietin Stimulating Agents market.
Major players in the global Erythropoietin Stimulating Agents market include:
Celon Labs
Celltrion, Inc.
LG Life Sciences Ltd.
Hospira Inc.
Probiomed
Intas Pharmaceuticals
Ranbaxy Laboratories Ltd.
Roche
Zuventus Health Care
Serum Institute of India
VHB Life Sciences Ltd.
Teva Pharmaceutical Industries Ltd.
Wockhardt Limited
Amgen Inc.
Johnson & Johnson
Biosidus
Biocon
Blausiegel
On the basis of types, the Erythropoietin Stimulating Agents market is primarily split into:
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
On the basis of applications, the market covers:
Cancer
Hematology
Renal Diseases
Neurology
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Erythropoietin Stimulating Agents market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Erythropoietin Stimulating Agents market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Erythropoietin Stimulating Agents industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Erythropoietin Stimulating Agents market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Erythropoietin Stimulating Agents, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Erythropoietin Stimulating Agents in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Erythropoietin Stimulating Agents in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Erythropoietin Stimulating Agents. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Erythropoietin Stimulating Agents market, including the global production and revenue forecast, regional forecast. It also foresees the Erythropoietin Stimulating Agents market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 ERYTHROPOIETIN STIMULATING AGENTS MARKET OVERVIEW
1.1 Product Overview and Scope of Erythropoietin Stimulating Agents
1.2 Erythropoietin Stimulating Agents Segment by Type
1.2.1 Global Erythropoietin Stimulating Agents Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Epoetin-alfa
1.2.3 The Market Profile of Epoetin-beta
1.2.4 The Market Profile of Darbepoetin-alfa
1.2.5 The Market Profile of Others
1.3 Global Erythropoietin Stimulating Agents Segment by Application
1.3.1 Erythropoietin Stimulating Agents Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Cancer
1.3.3 The Market Profile of Hematology
1.3.4 The Market Profile of Renal Diseases
1.3.5 The Market Profile of Neurology
1.4 Global Erythropoietin Stimulating Agents Market by Region (2014-2026)
1.4.1 Global Erythropoietin Stimulating Agents Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3 Europe Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.1 Germany Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.2 UK Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.3 France Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.4 Italy Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.5 Spain Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.6 Russia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.7 Poland Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.4 China Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.5 Japan Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.6 India Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8 Central and South America Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Erythropoietin Stimulating Agents (2014-2026)
1.5.1 Global Erythropoietin Stimulating Agents Revenue Status and Outlook (2014-2026)
1.5.2 Global Erythropoietin Stimulating Agents Production Status and Outlook (2014-2026)
2 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS MARKET LANDSCAPE BY PLAYER
2.1 Global Erythropoietin Stimulating Agents Production and Share by Player (2014-2019)
2.2 Global Erythropoietin Stimulating Agents Revenue and Market Share by Player (2014-2019)
2.3 Global Erythropoietin Stimulating Agents Average Price by Player (2014-2019)
2.4 Erythropoietin Stimulating Agents Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Erythropoietin Stimulating Agents Market Competitive Situation and Trends
2.5.1 Erythropoietin Stimulating Agents Market Concentration Rate
2.5.2 Erythropoietin Stimulating Agents Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Celon Labs
3.1.1 Celon Labs Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.1.3 Celon Labs Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.1.4 Celon Labs Business Overview
3.2 Celltrion, Inc.
3.2.1 Celltrion, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.2.3 Celltrion, Inc. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.2.4 Celltrion, Inc. Business Overview
3.3 LG Life Sciences Ltd.
3.3.1 LG Life Sciences Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.3.3 LG Life Sciences Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.3.4 LG Life Sciences Ltd. Business Overview
3.4 Hospira Inc.
3.4.1 Hospira Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.4.3 Hospira Inc. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.4.4 Hospira Inc. Business Overview
3.5 Probiomed
3.5.1 Probiomed Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.5.3 Probiomed Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.5.4 Probiomed Business Overview
3.6 Intas Pharmaceuticals
3.6.1 Intas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.6.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.6.4 Intas Pharmaceuticals Business Overview
3.7 Ranbaxy Laboratories Ltd.
3.7.1 Ranbaxy Laboratories Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.7.3 Ranbaxy Laboratories Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.7.4 Ranbaxy Laboratories Ltd. Business Overview
3.8 Roche
3.8.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.8.3 Roche Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.8.4 Roche Business Overview
3.9 Zuventus Health Care
3.9.1 Zuventus Health Care Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.9.3 Zuventus Health Care Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.9.4 Zuventus Health Care Business Overview
3.10 Serum Institute of India
3.10.1 Serum Institute of India Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.10.3 Serum Institute of India Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.10.4 Serum Institute of India Business Overview
3.11 VHB Life Sciences Ltd.
3.11.1 VHB Life Sciences Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.11.3 VHB Life Sciences Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.11.4 VHB Life Sciences Ltd. Business Overview
3.12 Teva Pharmaceutical Industries Ltd.
3.12.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.12.3 Teva Pharmaceutical Industries Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.12.4 Teva Pharmaceutical Industries Ltd. Business Overview
3.13 Wockhardt Limited
3.13.1 Wockhardt Limited Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.13.3 Wockhardt Limited Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.13.4 Wockhardt Limited Business Overview
3.14 Amgen Inc.
3.14.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.14.3 Amgen Inc. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.14.4 Amgen Inc. Business Overview
3.15 Johnson & Johnson
3.15.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.15.3 Johnson & Johnson Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.15.4 Johnson & Johnson Business Overview
3.16 Biosidus
3.16.1 Biosidus Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.16.3 Biosidus Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.16.4 Biosidus Business Overview
3.17 Biocon
3.17.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.17.3 Biocon Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.17.4 Biocon Business Overview
3.18 Blausiegel
3.18.1 Blausiegel Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.18.3 Blausiegel Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.18.4 Blausiegel Business Overview
4 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Erythropoietin Stimulating Agents Production and Market Share by Type (2014-2019)
4.2 Global Erythropoietin Stimulating Agents Revenue and Market Share by Type (2014-2019)
4.3 Global Erythropoietin Stimulating Agents Price by Type (2014-2019)
4.4 Global Erythropoietin Stimulating Agents Production Growth Rate by Type (2014-2019)
4.4.1 Global Erythropoietin Stimulating Agents Production Growth Rate of Epoetin-alfa (2014-2019)
4.4.2 Global Erythropoietin Stimulating Agents Production Growth Rate of Epoetin-beta (2014-2019)
4.4.3 Global Erythropoietin Stimulating Agents Production Growth Rate of Darbepoetin-alfa (2014-2019)
4.4.4 Global Erythropoietin Stimulating Agents Production Growth Rate of Others (2014-2019)
5 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS MARKET ANALYSIS BY APPLICATION
5.1 Global Erythropoietin Stimulating Agents Consumption and Market Share by Application (2014-2019)
5.2 Global Erythropoietin Stimulating Agents Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Cancer (2014-2019)
5.2.2 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Hematology (2014-2019)
5.2.3 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Renal Diseases (2014-2019)
5.2.4 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Neurology (2014-2019)
6 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Erythropoietin Stimulating Agents Consumption by Region (2014-2019)
6.2 United States Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.3 Europe Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.4 China Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.5 Japan Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.6 India Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
7 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Erythropoietin Stimulating Agents Production and Market Share by Region (2014-2019)
7.2 Global Erythropoietin Stimulating Agents Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
8 ERYTHROPOIETIN STIMULATING AGENTS MANUFACTURING ANALYSIS
8.1 Erythropoietin Stimulating Agents Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Erythropoietin Stimulating Agents
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Erythropoietin Stimulating Agents Industrial Chain Analysis
9.2 Raw Materials Sources of Erythropoietin Stimulating Agents Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Erythropoietin Stimulating Agents
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS MARKET FORECAST (2019-2026)
11.1 Global Erythropoietin Stimulating Agents Production, Revenue Forecast (2019-2026)
11.1.1 Global Erythropoietin Stimulating Agents Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Erythropoietin Stimulating Agents Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Erythropoietin Stimulating Agents Price and Trend Forecast (2019-2026)
11.2 Global Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Erythropoietin Stimulating Agents Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Erythropoietin Stimulating Agents Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Erythropoietin Stimulating Agents
1.2 Erythropoietin Stimulating Agents Segment by Type
1.2.1 Global Erythropoietin Stimulating Agents Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Epoetin-alfa
1.2.3 The Market Profile of Epoetin-beta
1.2.4 The Market Profile of Darbepoetin-alfa
1.2.5 The Market Profile of Others
1.3 Global Erythropoietin Stimulating Agents Segment by Application
1.3.1 Erythropoietin Stimulating Agents Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Cancer
1.3.3 The Market Profile of Hematology
1.3.4 The Market Profile of Renal Diseases
1.3.5 The Market Profile of Neurology
1.4 Global Erythropoietin Stimulating Agents Market by Region (2014-2026)
1.4.1 Global Erythropoietin Stimulating Agents Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3 Europe Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.1 Germany Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.2 UK Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.3 France Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.4 Italy Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.5 Spain Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.6 Russia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.3.7 Poland Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.4 China Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.5 Japan Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.6 India Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8 Central and South America Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Erythropoietin Stimulating Agents Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Erythropoietin Stimulating Agents (2014-2026)
1.5.1 Global Erythropoietin Stimulating Agents Revenue Status and Outlook (2014-2026)
1.5.2 Global Erythropoietin Stimulating Agents Production Status and Outlook (2014-2026)
2 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS MARKET LANDSCAPE BY PLAYER
2.1 Global Erythropoietin Stimulating Agents Production and Share by Player (2014-2019)
2.2 Global Erythropoietin Stimulating Agents Revenue and Market Share by Player (2014-2019)
2.3 Global Erythropoietin Stimulating Agents Average Price by Player (2014-2019)
2.4 Erythropoietin Stimulating Agents Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Erythropoietin Stimulating Agents Market Competitive Situation and Trends
2.5.1 Erythropoietin Stimulating Agents Market Concentration Rate
2.5.2 Erythropoietin Stimulating Agents Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Celon Labs
3.1.1 Celon Labs Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.1.3 Celon Labs Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.1.4 Celon Labs Business Overview
3.2 Celltrion, Inc.
3.2.1 Celltrion, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.2.3 Celltrion, Inc. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.2.4 Celltrion, Inc. Business Overview
3.3 LG Life Sciences Ltd.
3.3.1 LG Life Sciences Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.3.3 LG Life Sciences Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.3.4 LG Life Sciences Ltd. Business Overview
3.4 Hospira Inc.
3.4.1 Hospira Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.4.3 Hospira Inc. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.4.4 Hospira Inc. Business Overview
3.5 Probiomed
3.5.1 Probiomed Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.5.3 Probiomed Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.5.4 Probiomed Business Overview
3.6 Intas Pharmaceuticals
3.6.1 Intas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.6.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.6.4 Intas Pharmaceuticals Business Overview
3.7 Ranbaxy Laboratories Ltd.
3.7.1 Ranbaxy Laboratories Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.7.3 Ranbaxy Laboratories Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.7.4 Ranbaxy Laboratories Ltd. Business Overview
3.8 Roche
3.8.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.8.3 Roche Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.8.4 Roche Business Overview
3.9 Zuventus Health Care
3.9.1 Zuventus Health Care Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.9.3 Zuventus Health Care Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.9.4 Zuventus Health Care Business Overview
3.10 Serum Institute of India
3.10.1 Serum Institute of India Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.10.3 Serum Institute of India Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.10.4 Serum Institute of India Business Overview
3.11 VHB Life Sciences Ltd.
3.11.1 VHB Life Sciences Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.11.3 VHB Life Sciences Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.11.4 VHB Life Sciences Ltd. Business Overview
3.12 Teva Pharmaceutical Industries Ltd.
3.12.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.12.3 Teva Pharmaceutical Industries Ltd. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.12.4 Teva Pharmaceutical Industries Ltd. Business Overview
3.13 Wockhardt Limited
3.13.1 Wockhardt Limited Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.13.3 Wockhardt Limited Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.13.4 Wockhardt Limited Business Overview
3.14 Amgen Inc.
3.14.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.14.3 Amgen Inc. Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.14.4 Amgen Inc. Business Overview
3.15 Johnson & Johnson
3.15.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.15.3 Johnson & Johnson Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.15.4 Johnson & Johnson Business Overview
3.16 Biosidus
3.16.1 Biosidus Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.16.3 Biosidus Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.16.4 Biosidus Business Overview
3.17 Biocon
3.17.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.17.3 Biocon Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.17.4 Biocon Business Overview
3.18 Blausiegel
3.18.1 Blausiegel Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Erythropoietin Stimulating Agents Product Profiles, Application and Specification
3.18.3 Blausiegel Erythropoietin Stimulating Agents Market Performance (2014-2019)
3.18.4 Blausiegel Business Overview
4 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Erythropoietin Stimulating Agents Production and Market Share by Type (2014-2019)
4.2 Global Erythropoietin Stimulating Agents Revenue and Market Share by Type (2014-2019)
4.3 Global Erythropoietin Stimulating Agents Price by Type (2014-2019)
4.4 Global Erythropoietin Stimulating Agents Production Growth Rate by Type (2014-2019)
4.4.1 Global Erythropoietin Stimulating Agents Production Growth Rate of Epoetin-alfa (2014-2019)
4.4.2 Global Erythropoietin Stimulating Agents Production Growth Rate of Epoetin-beta (2014-2019)
4.4.3 Global Erythropoietin Stimulating Agents Production Growth Rate of Darbepoetin-alfa (2014-2019)
4.4.4 Global Erythropoietin Stimulating Agents Production Growth Rate of Others (2014-2019)
5 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS MARKET ANALYSIS BY APPLICATION
5.1 Global Erythropoietin Stimulating Agents Consumption and Market Share by Application (2014-2019)
5.2 Global Erythropoietin Stimulating Agents Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Cancer (2014-2019)
5.2.2 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Hematology (2014-2019)
5.2.3 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Renal Diseases (2014-2019)
5.2.4 Global Erythropoietin Stimulating Agents Consumption Growth Rate of Neurology (2014-2019)
6 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Erythropoietin Stimulating Agents Consumption by Region (2014-2019)
6.2 United States Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.3 Europe Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.4 China Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.5 Japan Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.6 India Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Erythropoietin Stimulating Agents Production, Consumption, Export, Import (2014-2019)
7 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Erythropoietin Stimulating Agents Production and Market Share by Region (2014-2019)
7.2 Global Erythropoietin Stimulating Agents Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Erythropoietin Stimulating Agents Production, Revenue, Price and Gross Margin (2014-2019)
8 ERYTHROPOIETIN STIMULATING AGENTS MANUFACTURING ANALYSIS
8.1 Erythropoietin Stimulating Agents Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Erythropoietin Stimulating Agents
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Erythropoietin Stimulating Agents Industrial Chain Analysis
9.2 Raw Materials Sources of Erythropoietin Stimulating Agents Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Erythropoietin Stimulating Agents
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS MARKET FORECAST (2019-2026)
11.1 Global Erythropoietin Stimulating Agents Production, Revenue Forecast (2019-2026)
11.1.1 Global Erythropoietin Stimulating Agents Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Erythropoietin Stimulating Agents Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Erythropoietin Stimulating Agents Price and Trend Forecast (2019-2026)
11.2 Global Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Erythropoietin Stimulating Agents Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Erythropoietin Stimulating Agents Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Erythropoietin Stimulating Agents Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
